CN101501075B - 支化透明质酸和制造方法 - Google Patents

支化透明质酸和制造方法 Download PDF

Info

Publication number
CN101501075B
CN101501075B CN2007800291575A CN200780029157A CN101501075B CN 101501075 B CN101501075 B CN 101501075B CN 2007800291575 A CN2007800291575 A CN 2007800291575A CN 200780029157 A CN200780029157 A CN 200780029157A CN 101501075 B CN101501075 B CN 101501075B
Authority
CN
China
Prior art keywords
hyaluronic acid
branched
glucosamine
deacetylated
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007800291575A
Other languages
English (en)
Chinese (zh)
Other versions
CN101501075A (zh
Inventor
克里斯托弗·托梅拉斯
卡迪加·施瓦克-阿卜杜拉奥伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes Biopharma DK AS
Original Assignee
Novozymes Biopharma DK AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes Biopharma DK AS filed Critical Novozymes Biopharma DK AS
Publication of CN101501075A publication Critical patent/CN101501075A/zh
Application granted granted Critical
Publication of CN101501075B publication Critical patent/CN101501075B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)
CN2007800291575A 2006-08-04 2007-07-13 支化透明质酸和制造方法 Expired - Fee Related CN101501075B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200601034 2006-08-04
DKPA200601034 2006-08-04
PCT/DK2007/000358 WO2008014787A1 (en) 2006-08-04 2007-07-13 Branched hyaluronic acid and method of manufacture

Publications (2)

Publication Number Publication Date
CN101501075A CN101501075A (zh) 2009-08-05
CN101501075B true CN101501075B (zh) 2013-07-10

Family

ID=38659373

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800291575A Expired - Fee Related CN101501075B (zh) 2006-08-04 2007-07-13 支化透明质酸和制造方法

Country Status (7)

Country Link
US (1) US8202986B2 (https=)
EP (1) EP2049572A1 (https=)
JP (1) JP2009545637A (https=)
CN (1) CN101501075B (https=)
AU (1) AU2007280846B2 (https=)
CA (1) CA2657823A1 (https=)
WO (1) WO2008014787A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI561535B (en) 2011-10-06 2016-12-11 Bvw Holding Ag Copolymers of hydrophobic and hydrophilic segments that reduce protein adsorption
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
CZ2014150A3 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
US10363595B2 (en) 2014-06-09 2019-07-30 Hyperion Materials & Technologies (Sweden) Ab Cemented carbide necking tool
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ306479B6 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
KR101969446B1 (ko) * 2017-06-30 2019-04-16 한양대학교 산학협력단 히알루론산 기반 보습 소재

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1468262A (zh) * 2000-10-10 2004-01-14 LG��ѧ��ʽ���� 透明质酸的交联酰胺衍生物及其生产方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60251898A (ja) 1984-05-25 1985-12-12 Shiseido Co Ltd 醗酵法によるヒアルロン酸の製造方法
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
JP2739232B2 (ja) * 1989-04-14 1998-04-15 チッソ株式会社 生物学的親和性を有するセルロースゲルの使用方法
IT1271001B (it) 1994-07-26 1997-05-26 Poli Ind Chimica Spa Procedimento di preparazione di acido ialuronico mediante fermentazione con streptococcus
IT1282219B1 (it) 1995-12-20 1998-03-16 Fidia Advanced Biopolymers Srl Processo chimico fisico combinato per la preparazione di frazioni di acido ialuronico a basso peso molecolare caratterizzate da bassa
CN1322121C (zh) 1997-10-31 2007-06-20 俄克拉何马大学董事会 透明质酸合酶基因及其应用
EP1832662B1 (en) 1998-04-02 2011-03-09 The Board Of Regents Of The University Of Oklahoma DNA encoding chondroitin synthase from Pasteurella multocida and methods of use
IT1303735B1 (it) * 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
DE69940353D1 (en) 1998-11-11 2009-03-12 Univ Oklahoma Polymerpfropfung mittels polysaccharide-synthase
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
JP2000248002A (ja) * 1999-02-19 2000-09-12 Denki Kagaku Kogyo Kk 自己架橋ヒアルロン酸とその製造方法及びその用途
GB2358637A (en) * 2000-01-27 2001-08-01 Btg Int Ltd Chitosan condensation products with a bisulphite addition compound
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
ITTS20010013A1 (it) * 2001-06-04 2002-12-04 Ct Ricerche Poly Tec H A R L S Nuovi derivati di ialuronano.
AU2002366711C1 (en) 2001-12-21 2009-01-22 Novozymes A/S Methods for producing hyaluronan in a recombinant host cell
TW200307011A (en) * 2002-04-18 2003-12-01 Chugai Pharmaceutical Co Ltd Hyaluronic acid modifier
KR100507545B1 (ko) * 2002-09-03 2005-08-09 주식회사 엘지생명과학 히알루론산 유도체 및 그의 제조방법
ITPD20020271A1 (it) * 2002-10-18 2004-04-19 Fidia Farmaceutici Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.
WO2005023906A1 (ja) * 2003-09-08 2005-03-17 Chugai Seiyaku Kabushiki Kaisha ヒアルロン酸修飾物、及びそれを用いた薬物担体

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1468262A (zh) * 2000-10-10 2004-01-14 LG��ѧ��ʽ���� 透明质酸的交联酰胺衍生物及其生产方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Crescenzi等.New cross-linked and sulfated derivatives of partially deacetylated hyaluronan:Synthesis and preliminary characterization.《Biopolymers》.2002,86-94. *

Also Published As

Publication number Publication date
JP2009545637A (ja) 2009-12-24
AU2007280846B2 (en) 2012-06-14
US20090312283A1 (en) 2009-12-17
US8202986B2 (en) 2012-06-19
EP2049572A1 (en) 2009-04-22
WO2008014787A1 (en) 2008-02-07
CA2657823A1 (en) 2008-02-07
AU2007280846A1 (en) 2008-02-07
CN101501075A (zh) 2009-08-05

Similar Documents

Publication Publication Date Title
CN101501075B (zh) 支化透明质酸和制造方法
Saranraj et al. Hyaluronic acid production and its applications-a review
US8481080B2 (en) Method of cross-linking hyaluronic acid with divinulsulfone
CN101415732B (zh) 芳基/脂族烃基乙烯基砜透明质酸衍生物
CN101273065B (zh) 芳基/脂族烃基琥珀酸酐乙酰透明质酸衍生物
US20080057091A1 (en) Compositions with several hyaluronic acid fractions for cosmetic use
US20080003271A1 (en) Compositions with Several Hyaluronic Acid Fractions for Cosmetic Use
CN101500535A (zh) 用于化妆品和医学用途的具有几种透明质酸级分的组合物
Fakhari Biomedical application of hyaluronic acid nanoparticles
US8039447B2 (en) Derivatives of hyaluronic acid, their preparation process and their uses
Saed et al. Innovative strategies for biotechnological production of hyaluronic acid from different sources
Omer et al. High-molecular weight biopolymer
Ghassemi et al. Hyaluronic acid: biological functions, production strategies, and clinical applications
Fallacara et al. polymers MDPI
Omer et al. A Review on Hyaluronan Biopolymer: Properties and Pharmaceutical Applications
Mohamed High-molecular weight of biopolymer
Stern Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett
Cai Glycosaminoglycans and their binding proteins: Biochemical studies and development of potential wound healing biomaterials

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
ASS Succession or assignment of patent right

Owner name: NOVOZYMES BIOLOGICGAL PHARMACEUTICAL DENMARK CO.,L

Free format text: FORMER OWNER: NOVOZYMES BIOPOLYMER AS

Effective date: 20090731

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20090731

Address after: Denmark bagsvaerd

Applicant after: Novozymes Biopharma DK A/S

Address before: Denmark bagsvaerd

Applicant before: Novozymes Biopolymer AS

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130710

Termination date: 20150713

EXPY Termination of patent right or utility model